[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2171459T3 - Polvo para administracion nasal de farmaco peptidico o proteinaceo. - Google Patents

Polvo para administracion nasal de farmaco peptidico o proteinaceo.

Info

Publication number
ES2171459T3
ES2171459T3 ES94921840T ES94921840T ES2171459T3 ES 2171459 T3 ES2171459 T3 ES 2171459T3 ES 94921840 T ES94921840 T ES 94921840T ES 94921840 T ES94921840 T ES 94921840T ES 2171459 T3 ES2171459 T3 ES 2171459T3
Authority
ES
Spain
Prior art keywords
peptidic
nasal administration
proteinaceo
pharmaco
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94921840T
Other languages
English (en)
Inventor
Masahiko Dohi
Yoshihisa Nishibe
Yuji Makino
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ES2171459T3 publication Critical patent/ES2171459T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60H—ARRANGEMENTS OF HEATING, COOLING, VENTILATING OR OTHER AIR-TREATING DEVICES SPECIALLY ADAPTED FOR PASSENGER OR GOODS SPACES OF VEHICLES
    • B60H1/00—Heating, cooling or ventilating [HVAC] devices
    • B60H1/00485—Valves for air-conditioning devices, e.g. thermostatic valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UN POLVO PARA LA ADMINISTRACION NASAL DE DROGAS PEPTIDICAS O PROTEINACEAS QUE COMPRENDE: I) UN SORBEFACIENTE QUE COMPRENDE UN COMPUESTO QUE TIENE UN GRUPO REPRESENTADO POR LA FORMULA GENERAL (I) EN SU MOLECULA, (EN DONDE EL ANILLO (A) REPRESENTA UN ANILLO DE CICLOHEXANO O DE BENCENO QUE PUEDE ESTAR SUSTITUIDO AL MENOS EN LA POSICION 3, 4 O 5; Y N REPRESENTA UN ENTERO ENTRE 1 Y 3) O UNA SAL DEL MISMO, Y (II) UNA DROGA PEPTIDICA O PROTEINACEA EN UNA DOSIS TERAPEUTICAMENTE EFECTIVA.
ES94921840T 1993-07-30 1994-07-29 Polvo para administracion nasal de farmaco peptidico o proteinaceo. Expired - Lifetime ES2171459T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20692293 1993-07-30
JP23584193 1993-08-30
JP164494 1994-01-12

Publications (1)

Publication Number Publication Date
ES2171459T3 true ES2171459T3 (es) 2002-09-16

Family

ID=27275015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94921840T Expired - Lifetime ES2171459T3 (es) 1993-07-30 1994-07-29 Polvo para administracion nasal de farmaco peptidico o proteinaceo.

Country Status (9)

Country Link
US (1) US5578324A (es)
EP (1) EP0667163B1 (es)
JP (1) JP2974412B2 (es)
KR (1) KR100327563B1 (es)
AT (1) ATE215377T1 (es)
CA (1) CA2145302C (es)
DE (1) DE69430295T2 (es)
ES (1) ES2171459T3 (es)
WO (1) WO1995003818A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co DRUG
JP3263598B2 (ja) * 1995-11-01 2002-03-04 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
DK0943326T4 (da) * 1996-02-27 2007-01-22 Teijin Ltd Pulveragtigt præparat til nasal administration
ATE331532T1 (de) * 1998-08-26 2006-07-15 Teijin Ltd Pulverförmige pernasale mittel
US7439063B2 (en) * 2002-06-11 2008-10-21 Burnham Institute For Medical Research Neuroprotective synergy of erythropoietin and insulin-like growth factors
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
JP2008019245A (ja) * 2006-06-15 2008-01-31 Japan Science & Technology Agency ヒューマニン誘導体又は該誘導体と神経向性ペプチドとの融合ペプチドを有効成分として含有する、アルツハイマー病予防・治療用の経鼻投与剤
WO2018097274A1 (ja) 2016-11-28 2018-05-31 ポーラ化成工業株式会社 シワ改善剤
JP7102658B2 (ja) * 2018-05-29 2022-07-20 ポーラ化成工業株式会社 美白用組成物
WO2019230274A1 (ja) * 2018-05-29 2019-12-05 ポーラ化成工業株式会社 美白剤
JP7102657B2 (ja) * 2018-05-29 2022-07-20 ポーラ化成工業株式会社 シワ改善用組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258030A (en) * 1979-03-07 1981-03-24 Zeria-Shinyaku Kogyo Kabushiki Kaisha Urokinase preparation for oral administration
DE3514508A1 (de) * 1985-04-22 1986-10-30 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Verwendung von dopamin und dessen ester bei der behandlung von glaukom
JPH01308235A (ja) * 1988-06-03 1989-12-12 Yamanouchi Pharmaceut Co Ltd ヒト成長ホルモン経鼻剤
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
JPH04235923A (ja) * 1991-01-16 1992-08-25 Kyowa Hakko Kogyo Co Ltd 経鼻投与用製剤
JPH04300817A (ja) * 1991-03-27 1992-10-23 Shiseido Co Ltd 口腔用組成物
JPH0558908A (ja) * 1991-09-05 1993-03-09 Mitsubishi Kasei Corp カルシトニン点鼻用医薬組成物
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
JP3047948B2 (ja) * 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物

Also Published As

Publication number Publication date
WO1995003818A1 (fr) 1995-02-09
KR950703352A (ko) 1995-09-20
ATE215377T1 (de) 2002-04-15
JP2974412B2 (ja) 1999-11-10
EP0667163A4 (en) 2000-04-19
KR100327563B1 (ko) 2002-08-24
DE69430295D1 (de) 2002-05-08
CA2145302C (en) 2008-10-28
DE69430295T2 (de) 2002-10-31
US5578324A (en) 1996-11-26
CA2145302A1 (en) 1995-02-09
EP0667163B1 (en) 2002-04-03
EP0667163A1 (en) 1995-08-16

Similar Documents

Publication Publication Date Title
KR870005637A (ko) 약물 데포
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
UY26320A1 (es) Sales farmaceuticas de la sustancia activa tramadol y al menos un edulcorante, medicamentos que contienen estas sales, el uso de estas sales para la preparacion de medicamentos y formas de administracion que contienen esas sales. ley 17164
AR004179A1 (es) Sales de (endo,sin)-(-)-3-(3-hidroxi-1-oxo-2-fenilpropoxi)-8-metil-8-(1- metiletil)-8-azoniabiciclo[3.2.1] octano y preparaciones medicamentosasinhalativas que las contienen.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
ATE79619T1 (de) Arzneimittel.
ES2159591T3 (es) Composicion de liberacion controlada.
BR9508287A (pt) Formulaçao para a aplicaçao por inalaçao
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
NO306457B1 (no) 2,4-disulfonylfenylbutylnitron, salter derav, farmasöytisk sammensetning, samt anvendelse av denne forbindelse til fremstilling av et medikament
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
ES2028796T3 (es) Procedimiento para producir preparados farmaceuticos que contienen interferon alfa.
DK515489D0 (da) Dispergerbar laegemiddelformulering
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
KR890009400A (ko) 다이클로닌 Hcl및 페놀을 함유하는 약제학적 조성물
ATE65395T1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 667163

Country of ref document: ES